Close

Analyst Ratings for Sunesis Pharmaceuticals Inc. (SNSS) [Neutrals]

SNSS Rating Summary

  |   Expand Research on SNSS
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 3.8 / 10   Percentile Rank: 36%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/11/2020 Wells Fargo Jim Birchenough Downgrade Equal Weight
(Overweight)
1.00
(N/A)
0.97
(5.32)
448.45% Details
12/20/2018 H.C. Wainwright
» Updated 3/11/2020
Andrew Fein New Coverage Neutral
(N/A)
1.00
(0.50)
0.30
(5.32)
1673.33% Details